Contextualized daily prediction of lapse risk in opioid use disorder by digital phenotyping.
National Institute on Drug Abuse (R01 DA047315)
John Curtin (Co-PI), Dhavan Shah (Co-PI), Xiaojin Zhu (Co-I), David Gustafson (Co-I), Randy Brown (Co-I), William Sethares (Co-I), Qunying Huang (Co-I)
Direct Costs: $2,238,540
Status: Funded. 08/01/2019 – 06/30/2024
Real-time predictors of prescription drug misuse by college students and assessment of misuse on their developmental trajectories.
National Institute on Drug Abuse (R01 DA042093)
Lauren M Papp (PI), John Curtin (Co-I)
Direct Costs: $1,574,300
Status: Funded. 04/01/2017 – 02/28/2022
RCT targeting noradrenergic stress mechanisms in alcoholism with doxazosin.
National Institute of Alcohol Abuse and Alcoholism (R01 AA024388)
John Curtin (PI), Craig Berridge (Co-I), Aleksandra Zgierska (Co-I)
Direct Costs: $1,420,889
Status: Funded. 09/01/2015 – 05/31/2020
Dynamic, real-time prediction of alcohol use lapse using mHealth technologies.
National Institute of Alcohol Abuse and Alcoholism (R01 AA024391)
John Curtin (PI), Xiaojin Zhu (Co-I), Oguzhan Alagoz (Co-I), David Gustafson (Co-I)
Direct Costs: $1,237,770
Status: Funded. 08/10/2015 – 05/31/2020
Clinical relevance of stress neuroadaptation in tobacco dependence.
National Institute on Drug Abuse (R01 DA033809)
John Curtin (PI), Timothy Baker (Co-I), Megan Piper (Co-I), Daniel Bolt (Co-I)
Direct costs: $1,508,145
Status: Funded. 08/2012 – 06/2018
Noradrenergic stress mechanisms in alcoholism: Preclinical translation and drug repurposing.
University of Wisconsin, Office of the Vice Chancellor for Research and Graduate Education
John Curtin (PI)
Direct costs: $36,097
Status: Funded. 07/2015 – 06/2016